Market Research Logo

Radiation Therapy Global Market – Forecast To 2024

Radiation Therapy Global Market – Forecast To 2024

Radiation is one of the most common treatments for cancer and may be delivered by a machine outside the body (external-beam radiation therapy), or it may be delivered by a radioactive material placed in the body near cancer cells (internal radiation therapy/ brachytherapy), or by systemic radiation therapy which uses radioactive substances, such as radioactive iodine, that travel in the blood to kill cancer cells. About half of all cancer patients receive some type of radiation therapy sometime during the course of their treatment. Radiation therapy is sometimes given with curative intent. In such cases, radiation therapy may be used alone or in combination with surgery, chemotherapy, or both. It may also be given with palliative intent, which is not intended to cure; instead they relieve symptoms and reduce the suffering caused by cancer. For example, radiation given to the brain to shrink tumours formed from cancer cells that have spread to the brain from another part of the body. Radiation therapy kills cancer cells either by damaging DNA directly or creates charged particles (free radicals) within the cells that can in turn damage the DNA, but does not travel throughout the body as chemotherapy treatment does. But, it can cause side effects, damaging healthy cells and tissues surrounding the tumour cells, in turn can also damage the surrounding organs and it may also leads to develop a secondary cancer as a result of exposure to radiation. Today, major advances in radiation technology have made it more precise, leading to fewer side effects with the modern ways of giving radiation therapy and careful treatment planning aim to reduce the risk of these complications. The radiation therapy global market is expected to grow at mid single digit CAGR to reach 8,680.6 million by 2024.

The radiation therapy market is segmented based on their products, technology, end-users and geography. The radiation therapy market by products is segmented into external radiation therapy products, internal radiation therapy products and systemic radiation therapy products. The external radiation therapy products are further segmented into Linear accelerators (Linacs) and proton therapy systems. The internal radiation therapy product is further segmented into seeds, applicators & afterloaders, others (electronic brachytherapy & accessories) and systemic radiation therapy products are further segmented into alpha emitters and beta emitters. Based on technologies, the radiation therapy market is segmented into external radiation therapy technologies, internal radiation therapies and systemic radiation therapy technologies. External radiation therapy technologies are further segmented into Stereotactic radio surgery (SRS), Stereotactic body radiation therapy (SBRT), Image-guided radiation therapy (IGRT), Intensity-modulated radiation therapy (IMRT); Volumetric modulated arc therapy (VMAT), Intensity-modulated proton therapy (IMPT) and others. Internal radiation therapy technology is further segmented into High dose rate brachytherapy, low dose rate brachytherapy and others. Based on applications, radiation therapy market is segmented into prostate cancer, breast cancer, gynaecological cancer, gastrointestinal cancer, lung cancer, brain cancer, head & neck cancer and others. Based on end-users, radiation therapy market is segmented into hospitals, radiation therapy centres, ambulatory surgical centres and others. Further the radiation therapy global market is separated by geographical regions into North America, Europe, Asia-pacific and Rest of the World. North America is further segmented into U.S. and Others. Europe is further segmented into Germany, Italy, France, and others. Asia-pacific region is further segmented into China, Japan, India and others and Rest of the world is further segmented into Brazil, Rest of Latin America and Middle East & Others.


1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.4 MARKET DYNAMICS
3.4.1 DRIVERS AND OPPORTUNITIES
3.4.1.1 Growing prevalence of cancer cases
3.4.1.2 Adoption of unhealthy lifestyle
3.4.1.3 Technological advancements
3.4.1.4 Rising preference for non-invasive procedures of cancer treatment
3.4.1.5 Rapid rise in geriatric population
3.4.2 RESTRAINTS AND THREATS
3.4.2.1 Side effects associated with the radiation therapy
3.4.2.2 Lack of sufficient infrastructure and skilled technicians in low and middle income countries
3.4.2.3 Lack of awareness and understanding about radiation therapy’s importance
3.4.2.4 High cost of radiation therapy devices
3.4.2.5 Stringent regulatory requirements
3.5 REGULATORY AFFAIRS
3.5.1 U.S.
3.5.2 EUROPE
3.5.3 CHINA
3.5.4 INDIA
3.5.5 JAPAN
3.6 REIMBURSEMENT SCENARIO
3.6.1 REIMBURSEMENT TABLE
3.7 CLINICAL TRIAL DATA
3.8 PATENT TRENDS
3.9 TECHNOLOGICAL ADVANCEMENTS
3.9.1 INTRODUCTION
3.9.1.1 Advancements in linear accelerator technology
3.9.1.2 MRI-guided radiation therapy
3.9.1.3 Proton therapy
3.10 FUNDING SCENARIO
3.11 PORTER’S FIVE FORCE ANALYSIS
3.11.1 THREAT OF NEW ENTRANTS
3.11.2 THREAT OF SUBSTITUTES
3.11.3 BARGAINING POWER OF SUPPLIERS
3.11.4 BARGAINING POWER OF BUYERS
3.11.5 RIVALRY AMONG EXISTING COMPETITORS
3.12 SUPPLY CHAIN ANALYSIS
3.13 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.13.1 MARKET SHARE ANALYSIS OF LINAC BY MAJOR PLAYERS
3.13.2 LINAC INSTALLED BASE GLOBAL MARKET SHARE, BY REGION
3.13.3 MARKET SHARE ANALYSIS OF PROTON THERAPY SYSTEMS BY MAJOR PLAYERS
3.13.4 MARKET SHARE ANALYSIS OF BRACHYTHERAPY BY MAJOR PLAYERS
3.13.5 BRACHYTHERAPY INSTALLED BASE GLOBAL MARKET SHARE, BY
REGION
3.13.6 MARKET SHARE ANALYSIS OF ELECTRONIC BRACHYTHERAPY, BY
MAJOR PLAYERS
4 RADIATION THERAPY GLOBAL MARKET, BY PRODUCT TYPE
4.1 INTRODUCTION
4.2 EXTERNAL BEAM RADIATION THERAPY
4.2.1 LINEAR ACCELERATORS (LINACS)
4.2.2 PROTON THERAPY SYSTEMS
4.3 INTERNAL RADIATION THERAPY
4.3.1 SEEDS
4.3.2 APPLICATORS & AFTERLOADERS
4.3.3 OTHERS (ELECTRONIC BRACHYTHERAPY & ACCESSORIES)
4.4 SYSTEMIC RADIATION THERAPY
4.4.1 ALPHA EMITTERS
4.4.2 BETA EMITTERS
5 RADIATION THERAPY GLOBAL MARKET, BY TECHNOLOGY
5.1 INTRODUCTION
5.2 EXTERNAL RADIATION THERAPY
5.2.1 IMAGE-GUIDED RADIATION THERAPY (IGRT)
5.2.2 INTENSITY-MODULATED RADIATION THERAPY (IMRT)
5.2.3 VOLUMETRIC MODULATED ARC THERAPY (VMAT)
5.2.4 STEREOTACTIC BODY RADIATION THERAPY (SBRT)
5.2.5 STEREOTACTIC RADIOSURGERY (SRS)
5.2.6 INTENSITY MODULATED PROTON THERAPY (IMPT)
5.2.7 OTHER EXTERNAL RADIATION THERAPIES
5.3 INTERNAL RADIATION THERAPY
5.3.1 HIGH DOSE RATE (HDR) BRACHYTHERAPY
5.3.2 LOW DOSE RATE (LDR) BRACHYTHERAPY
5.3.3 OTHER INTERNAL RADIATION THERAPIES
5.4 SYSTEMIC RADIATION THERAPY
6 RADIATION THERAPY GLOBAL MARKET BY APPLICATIONS
6.1 INTRODUCTION
6.1.1 PROSTATE CANCER
6.1.2 GYNAECOLOGY CANCERS
6.1.3 BREAST CANCER
6.1.4 HEAD & NECK CANCER
6.1.5 LUNG CANCER
6.1.6 BRAIN CANCER
6.1.7 GASTROINTESTINAL CANCER
6.1.8 OTHERS
7 RADIATION THERAPY GLOBAL MARKET, BY END-USERS
7.1 INTRODUCTION
7.2 HOSPITALS
7.3 AMBULATORY SURGICAL CENTRES
7.4 RADIATION THERAPY SPECIALITY CENTRES
7.5 OTHERS
8 REGIONAL ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 U.S.
8.2.2 OTHERS
8.3 EUROPE
8.3.1 GERMANY
8.3.2 ITALY
8.3.3 FRANCE
8.3.4 OTHERS
8.4 ASIA PACIFIC (APAC)
8.4.1 CHINA
8.4.2 JAPAN
8.4.3 INDIA
8.4.4 OTHERS
8.5 REST OF THE WORLD (ROW)
8.5.1 BRAZIL
8.5.2 REST OF LATIN AMERICA
8.5.3 MIDDLE EAST AND OTHERS
9 COMPETITIVE LANDSCAPE
9.1 INTRODUCTION
9.2 AGREEMENTS, PARTNERSHIPS AND COLLABORATIONS
9.3 APPROVALS
9.4 NEW PRODUCT LAUNCH
9.5 ACQUISITIONS
9.6 OTHER DEVELOPMENTS
10 MAJOR COMPANIES
10.1 ACCURAY, INCORPORATED
10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 PRODUCT PORTFOLIO
10.1.4 KEY DEVELOPMENTS
10.1.5 BUSINESS STRATEGY
10.1.6 SWOT ANALYSIS
10.2 BAYER AG
10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 PRODUCT PORTFOLIO
10.2.4 KEY DEVELOPMENTS
10.2.5 BUSINESS STRATEGY
10.2.6 SWOT ANALYSIS
10.3 BRAINLAB AG
10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.3 PRODUCT PORTFOLIO
10.3.4 KEY DEVELOPMENTS
10.3.5 BUSINESS STRATEGY
10.3.6 SWOT ANALYSIS
10.4 C.R.BARD INC.
10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.3 PRODUCT PORTFOLIO
10.4.4 KEY DEVELOPMENTS
10.4.5 BUSINESS STRATEGY
10.4.6 SWOT ANALYSIS
10.5 CARL ZEISS MEDITEC AG
10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.3 PRODUCT PORTFOLIO
10.5.4 KEY DEVELOPMENTS
10.5.5 BUSINESS STRATEGY
10.5.6 SWOT ANALYSIS
10.6 ECKERT & ZIEGLER BIBEG
10.6.1 OVERVIEW
10.6.2 FINANCIALS
10.6.3 PRODUCT PORTFOLIO
10.6.4 KEY DEVELOPMENTS
10.6.5 BUSINESS STRATEGY
10.6.6 SWOT ANALYSIS
10.7 ELEKTA AB
10.7.1 OVERVIEW
10.7.2 FINANCIALS
10.7.3 PRODUCT PORTFOLIO
10.7.4 KEY DEVELOPMENTS
10.7.5 BUSINESS STRATEGY
10.7.6 SWOT ANALYSIS
10.8 HITACHI MEDICAL CORPORATION
10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.3 PRODUCT PORTFOLIO
10.8.4 KEY DEVELOPMENTS
10.8.5 BUSINESS STRATEGY
10.8.6 SWOT ANALYSIS
10.9 IBA (ION BEAM APPLICATIONS S.A.)
10.9.1 OVERVIEW
10.9.2 FINANCIALS
10.9.3 PRODUCT PORTFOLIO
10.9.4 KEY DEVELOPMENTS
10.9.5 BUSINESS STRATEGY
10.9.6 SWOT ANALYSIS
10.10 MEVION MEDICAL SYSYTEMS.
10.10.1 OVERVIEW
10.10.2 FINANCIALS
10.10.3 PRODUCT PORTFOLIO
10.10.4 KEY DEVELOPMENTS
10.10.5 BUSINESS STRATEGY
10.10.6 SWOT ANALYSIS
10.11 RAYSEARCH LABORATORIES INC.,
10.11.1 OVERVIEW
10.11.2 FINANCIALS
10.11.3 PRODUCT PORTFOLIO
10.11.4 KEY DEVELOPMENTS
10.11.5 BUSINESS STRATEGY
10.11.6 SWOT ANALYSIS
10.12 VARIAN MEDICAL SYSTEMS, INC.
10.12.1 OVERVIEW
10.12.2 FINANCIALS
10.12.3 PRODUCT PORTFOLIO
10.12.4 KEY DEVELOPMENTS
10.12.5 BUSINESS STRATEGY
10.12.6 SWOT ANALYSIS
10.13 VIEWRAY, INC.,
10.13.1 OVERVIEW
10.13.2 FINANCIALS
10.13.3 PRODUCT PORTFOLIO
10.13.4 KEY DEVELOPMENTS
10.13.5 BUSINESS STRATEGY
10.13.6 SWOT ANALYSIS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report